The company is now focused on maximising performance and longevity for a range of medical supplies
US oil company ExxonMobil has expanded its portfolio of healthcare solutions to meet changing medical market needs for healthy, safe material options.
Adhering to industry requirements for testing, quality assurance and traceability, the portfolio unites a wide range of high-performance products that are produced using Good Manufacturing Practices (GMP) for batch-to-batch product consistency that customers can rely on.
The company is now focused on maximising performance and longevity for a range of medical supplies, delivering high-purity products for laboratory components and pharmaceutical packaging to meet the toughest standards and innovating to improve cleanliness and safety for better infection protection.
The portfolio provides the building blocks to engineer a range of applications including medical supplies, infection protection products, and pharmaceutical and laboratory supplies. The portfolio includes Achieve Advanced PP, ExxonMobil PP, Vistamaxx performance polymers, Exact polyolefin elastomers, ExxonMobil butyl polymers, Exxpro speciality elastomers and ExxonMobil Isopropyl Alcohol.
“The decision to create a portfolio of healthcare solutions, supported by a dedicated team of trusted industry application experts, was cemented by a combination of market factors, including the COVID-19 pandemic,” said Market Development Manager Gertrud Masure. “With a legacy of innovation that spans over 100 years, ExxonMobil is well placed to meet demand from customers for a broader selection of alternative solutions that promote healthy and safe patient care.”
The COVID-19 pandemic, which required rapid production of face masks and other products to help combat virus transmission, was a major factor in ExxonMobil’s decision to create a portfolio of healthcare solutions.
We seek to meet industry needs with a trusted portfolio of performance products that adhere to strict industry requirements for testing, quality assurance and traceability
The healthcare industry’s desire for a polyvinyl chloride (PVC) replacement was another market driver which led ExxonMobil to develop suitable alternatives. Another motivating factor was customers’ preference to do business with a single-source materials supplier.
ExxonMobil’s high-quality, compliant-safe material solutions enable tailored innovation for optimised performance and longevity of medical supplies, including drug/medical fluid delivery. Applications include syringes, infusion bags, IV/saline containers, ostomy bags, inhaling systems, drug and vitamin tubes, bottles, vials, containers, caps, seals, closures, briefs, and absorbent pads.
It also included purity required to meet the toughest standards for laboratory components and pharmaceutical packaging solutions, including labware, sanitizers, bio reactor bags, and pharmaceutical stoppers/seals.
Another thing that was looked at was cleanliness and safety for protective products, such as face masks, gowns, gloves and alcohol wipes that help prevent infection. Alongside this was softness, loft, strength, improved barrier performance and ease of processing for spunbond or meltblown nonwoven products. Typical applications include absorbent articles, medical PPE, bandages, masks, gowns and wipes, surgical drapes and gowns, medical protective gowns, shoe covers, disposable bedding and hospital apparel, pads, wraps, and filtration media.
“It really is the sum of the parts that makes our healthcare portfolio so attractive to customers,” said Americas Market Development Manager Abigail Agentis. “We seek to meet industry needs with a trusted portfolio of performance products that adhere to strict industry requirements for testing, quality assurance and traceability. Our collective motivation is to deliver innovative healthcare and pharmaceutical products that help enable patients to receive best-in-class, safe treatment.”
To support its commitment to the healthcare industry, ExxonMobil is dedicated to fulfilling the future business needs of its customers by continuing to invest in production capacity and comprehensive supply chains. For example, ExxonMobil’s Polypropylene Growth Project in Baton Rouge is nearing completion, and the company continues to make good progress in support of a 2023 startup of the $2 billion investment to expand its Baytown chemical plant with a new Vistamaxx unit and world-scale, full range Linear Alpha Olefins unit. Products from both are expected to be used for a broad range of applications.